Literature DB >> 4651777

The removal of 14 C-edrophonium from the circulation.

D J Back, T N Calvey.   

Abstract

The clearance of (14)C-edrophonium from plasma was studied in the rat. Distribution studies showed that 5 min after intravenous injection of the drug, more than half the dose was present in the liver and the kidneys. The concentration in these organs was approximately 20 times the level in other tissues. The plasma concentration of (14)C-edrophonium was invariably expressed as the sum of two exponential terms, suggesting that the drug may return to the circulation from other tissues as the plasma level falls.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4651777      PMCID: PMC1666356          DOI: 10.1111/j.1476-5381.1972.tb06882.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Active transport of quaternary ammonium compounds into bile.

Authors:  L S SCHANKER; H M SOLOMON
Journal:  Am J Physiol       Date:  1963-05

2.  Experimental studies on the fate of decamethonium.

Authors:  B GIOVANELLA; C MANNI; P MAZZONI; G MORICCA
Journal:  Can Anaesth Soc J       Date:  1961-09

3.  Renal tubular excretion of organic bases.

Authors:  L PETERS
Journal:  Pharmacol Rev       Date:  1960-03       Impact factor: 25.468

4.  Anticurare action of phenolic quaternary ammonium salts.

Authors:  L O RANDALL
Journal:  J Pharmacol Exp Ther       Date:  1950-09       Impact factor: 4.030

5.  The mechanism of anticurare action of certain neostigmine analogues.

Authors:  F HOBBIGER
Journal:  Br J Pharmacol Chemother       Date:  1952-06

6.  Microinjection study of p-aminohippurate excretion by rat kidneys.

Authors:  A D Baines; C W Gottschalk; W E Lassiter
Journal:  Am J Physiol       Date:  1968-04

7.  Bidirectional active transport of m-hydroxybenzoate in proximal tubule of dogs.

Authors:  D G May; I M Weiner
Journal:  Am J Physiol       Date:  1970-02

8.  Distribution and biliary excretion of decamethonium in doubly nephrectomized rabbits.

Authors:  C B Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

9.  Renal tubular reabsorption of p-aminohippuric acid (PAH)in the dog.

Authors:  K C Cho; E J Cafruny
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

10.  Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus.

Authors:  D J Back; T N Calvey
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

View more
  6 in total

1.  Proceedings: The relation between the plasma concentration of edrophonium, inhibition of erythrocyte acetylcholinesterase, and the facilitation of neuromuscular function in the rat.

Authors:  H E Barber; T N Calvey; K T Muir; K Taylor
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat.

Authors:  H E Barber; T N Calvey; K T Muir; K Taylor
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

3.  Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.

Authors:  K Yamamoto; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

4.  The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles.

Authors:  D J Back; T N Calvey
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

5.  Evaluation of the Edrophonium Challenge Test for Cervical Dystonia.

Authors:  Shinichi Matsumoto; Nagahisa Murakami; Hidetaka Koizumi; Masatoshi Takahashi; Yuishin Izumi; Ryuji Kaji
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

6.  Edrophonium Challenge Test for Blepharospasm.

Authors:  Shinichi Matsumoto; Nagahisa Murakami; Hidetaka Koizumi; Masatoshi Takahashi; Yuishin Izumi; Ryuji Kaji
Journal:  Front Neurosci       Date:  2016-06-06       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.